Prescription Drugs

• Retiree Group Endorses Joe Courtney for Re-election to U.S. House

  August 09, 2022: Cites Commitment to Expanding and Protecting Earned Social Security and Medicare Benefits, Lowering Drug Prices Members of the Alliance for Retired Americans proudly announced their endorsement of Joe Courtney for re-election to the U.S. House of ...Read more >

• Retirees Applaud Strong Senate Action to Lower Drug Prices for Millions of Older Americans

  August 07, 2022: Statement by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding passage of the Inflation Reduction Act (IRA) by the U.S. Senate: “Today 50 members of the U.S. Senate and Vice President Kamala Harris voted to put ...Read more >

• How Pfizer Won the Pandemic, Reaping Outsize Profit and Influence

  July 06, 2022: The grinding two-plus years of the pandemic have yielded outsize benefits for one company — Pfizer — making it both highly influential and hugely profitable as covid-19 continues to infect tens of thousands of people and kill hundreds each day. ...Read more >

• Sen. Warren, Experts Highlight Executive Actions to Lower Drug Prices

  May 02, 2022: In a letter to HHS Secretary Xavier Becerra, Senator Elizabeth Warren (MA) outlined a number of executive actions that the Biden administration could take to lower the cost of prescription drugs. Backed by legal and medical experts from Yale Law S...Read more >

• Big Pharma’s Lies on Drug Prices Debunked

  April 26, 2022: Last week, the Alliance joined the bipartisan patient coalition Patients for Affordable Drugs Now (P4ADN) as it implemented Debunking Big Pharma Week. Throughout the week, P4ADNow highlighted five of Big Pharma’s biggest lies to shed light on the t...Read more >

• Arizona Alliance Testifies at Sen. Kelly Hearing on Lowering Prescription Drug Prices

  April 18, 2022: Arizona Senator Mark Kelly chaired a U.S. Senate Special Committee on Aging hearing in Phoenix on Tuesday entitled, “No Time to Wait: Proposals to Lower Prescription Drug Costs.” Arizona experts, advocates, and patients impacted by rising drug pr...Read more >

• Medicare Limits Coverage of Aduhelm to Patients in Clinical Trials

  April 11, 2022: Citing data showing the new Alzheimer’s drug Aduhelm has serious safety risks and may not help patients, Medicare officials decided Thursday to limit coverage of the drug to patients in clinical trials. The decision is extremely unusual for Medicar...Read more >

• Alliance Praises House Passage of Legislation to Reduce the Price of Insulin

  April 04, 2022: The United States House of Representatives passed the Affordable Insulin Now Act, H.R. 6833, by a vote of 232-193 on March 31, capping the cost of insulin at $35 per month for all Medicare beneficiaries and many other Americans of all ages who need t...Read more >

• Retirees Praise Legislation to Reduce the Price of Insulin

  March 31, 2022: Statement by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding House passage of H.R. 6833, the "Affordable Insulin Now Act.” “Seniors are applauding the House of Representatives for passing the Affordable Insu...Read more >

• Democrats Eye Plans to Substantially Drop the Price of Insulin

  March 28, 2022: Senate Democrats are proposing legislation to cap insulin prices at $35 a month, after previous attempts to reduce drug prices stalled in Congress. The cap would likely be combined with a bipartisan bill targeting pharmacy middlemen known as pharmacy...Read more >